Novo Integrated Sciences, Inc. (NVOS)

Revenue by Segment

Financials in millions USD. Fiscal year is September - August.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020	Aug 31, 2019	Aug 31, 2018	Aug 31, 2017	Aug 31, 2016	Aug 31, 2015
Healthcare Services	8.30M	8.23M	8.40M	8.86M	7.86M
Healthcare Services Growth	0.86%	-2.04%	-5.19%	12.69%	-16.57%
Product Sales	4.92M	4.34M	3.34M	447.56K	-
Product Sales Growth	13.45%	29.93%	645.57%	-	-
Corporate	78.25K	9.70K	3.18K	-	-
Corporate Growth	706.70%	204.94%	-	-	-
Total	13.29M	12.57M	11.74M	9.31M	7.86M
Total Growth	5.75%	7.11%	26.14%	18.38%	-16.57%

Revenue by Geography

Financials in millions USD. Fiscal year is September - August.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020	Aug 31, 2019	Aug 31, 2018	Aug 31, 2017	Aug 31, 2016	Aug 31, 2015
Canada	13.29M	12.57M	11.74M	9.31M	7.86M
Canada Growth	5.75%	7.11%	26.14%	18.38%	-16.57%
Total	13.29M	12.57M	11.74M	9.31M	7.86M
Total Growth	5.75%	7.11%	26.14%	18.38%	-16.57%

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 26, 2026

Data Sources Report a data error